White label ELPA - ClinicalTrials.eu

Study on the Safety and Effects of Dasatinib in Patients with Recent HIV-1 Infection

Not recruiting

2 1 1
Investigated diseases:
- Asymptomatic HIV infection
Investigated drugs:
- Dasatinib
Study on Personalized Treatment for High-Risk Breast Cancer Using Palbociclib, Olaparib, and Pertuzumab in Patients with Advanced Disease

Not recruiting

2 1 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:
Study of CARCIK-CD19 Cells for Patients with Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia

Not recruiting

2 1 1
Investigated diseases:
- Acute lymphocytic leukaemia
Investigated drugs:
- Carcik-Cd19 Cells
Study on the Effects of Sitravatinib and Tislelizumab for Patients with Metastatic Uveal Melanoma and Liver Metastases

Not recruiting

2 1 1
Investigated diseases:
- Uveal melanoma
Investigated drugs:
- Sitravatinib Malate
- Tislelizumab
Study on the Safety and Effectiveness of Fedratinib and Azacitidine for Patients with Accelerated Phase Myelofibrosis

Not recruiting

1 1 1 1
Investigated diseases:
- Myelofibrosis
Investigated drugs:
- Fedratinib
- Azacitidine
Study on Mycobacterium Bovis Bacillus Calmette-Guérin for High-risk Non-muscle Invasive Bladder Cancer Patients

Not recruiting

2 1 1
Investigated diseases:
- Bladder cancer recurrent
- Bladder cancer
Study on the Effectiveness and Safety of Azacitidine, Gemcitabine, and Bendamustine Hydrochloride for Patients with Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma

Not recruiting

4 1 1 1
Investigated diseases:
- Angioimmunoblastic T-cell lymphoma refractory
Investigated drugs:
Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Olaparib
- Pembrolizumab
Study on Oxaliplatin for Reducing Recurrence Risk in High-Risk Colon Cancer Patients After Surgery

Not recruiting

2 1 1 1
Investigated diseases:
- Colon cancer
Investigated drugs:
- Oxaliplatin
Study on Rituximab for Patients with Generalized Myasthenia Gravis

Not recruiting

3 1 1
Investigated diseases:
- Myasthenia gravis
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies